Personalised medicine: Priority setting and opportunity costs in European public health care systems
Keywords:
Personalised medicine, Person, Priority setting, Opportunity costs, Health economicsAbstract
“Personalised medicine” is currently attracting considerable attention and raising high
hopes and expectations in modern medicine. The term “personalised medicine” denotes the
use of genetic or other biomarker information, and it does not focus on a more personal
patient-doctor relationship. Furthermore, personalised medicine is associated with ethical
problems like priority setting and opportunity costs in solidarity-based public health care
systems. Personalised medicine provides modern, highly specific and expensive diagnostics
and treatments, which serve only limited subgroups of patients. At the same time, research in
other fields of clinical medicine, which could be of benefit to more patients than such limited
subgroups, remain underfunded.
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
